Miller Matthew P 4
4 · Oncology Institute, Inc. · Filed Mar 23, 2022
Insider Transaction Report
Form 4
Miller Matthew P
Chief Operating Officer
Transactions
- Award
Common stock
2022-03-21+6,386→ 56,970 total - Award
Common stock
2022-03-21+21,641→ 78,611 total - Award
Stock Option (right to buy)
2022-03-21+5,186→ 5,186 totalExercise: $7.09Exp: 2032-03-21→ Common stock (5,186 underlying) - Award
Stock Option (right to buy)
2022-03-21+17,575→ 17,575 totalExercise: $7.09Exp: 2032-03-21→ Common stock (17,575 underlying)
Footnotes (4)
- [F1]Represents restricted stock units ("RSUs") that vest in four equal annual installments on each of the first four anniversaries of November 12, 2021 (the "Vesting Commencement Date"), with all RSUs becoming vested on the fourth anniversary of the Vesting Commencement Date, subject to continued service with the Company through such vesting dates.
- [F2]Represents RSUs with 1/3rd of the RSUs vesting on the second anniversary of the Vesting Commencement Date, with the remaining RSUs vesting in four equal annual installments beginning on the third anniversary of the Vesting Commencement Date, with all RSUs becoming vested on the sixth anniversary of the Vesting Commencement Date, subject to continued service with the Company through such vesting dates.
- [F3]The stock options vest in four equal annual installments on each of the first four anniversaries of the Vesting Commencement Date, with all options becoming vested on the fourth anniversary of the Vesting Commencement Date, subject to continued service with the Company through such vesting dates.
- [F4]The stock options vest as to 1/3rd of the options granted on the second anniversary of the Vesting Commencement Date, with the remaining options vesting in four equal annual installments beginning on the third anniversary of the Vesting Commencement Date, with all options becoming vested on the sixth anniversary of the Vesting Commencement Date, subject to continued service with the Company through such vesting dates.